West Pharmaceutical Services Stock Analysis

West Stock Analysis Notes

About 96.0% of the company outstanding shares are owned by institutional investors. The company recorded earning per share (EPS) of 7.04. West Pharmaceutical last dividend was issued on the 31st of July 2024. The entity had 2:1 split on the 27th of September 2013. West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania. West Pharmaceutical operates under Medical Instruments Supplies classification in the United States and is traded on New York Stock Exchange. It employs 10065 people. For more information please call Eric Green at 610 594 2900 or visit https://www.westpharma.com.

West Pharmaceutical Investment Alerts

West Pharmaceutical Upcoming and Recent Events

West Largest EPS Surprises

View All Earnings Estimates

West Pharmaceutical Environmental, Social, and Governance (ESG) Scores

West Pharmaceutical Thematic Classifications

West Stock Institutional Investors

Note, although West Pharmaceutical's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

West Market Capitalization

The company currently falls under 'Large-Cap' category with a total capitalization of 22 B.

West Profitablity

The company has Net Profit Margin of 0.18 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.18 %, which entails that for every 100 dollars of revenue, it generated $0.18 of operating income.

Management Efficiency

West Pharmaceutical has Return on Asset of 0.1066 % which means that on every $100 spent on assets, it made $0.1066 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1972 %, implying that it generated $0.1972 on every 100 dollars invested. West Pharmaceutical's management efficiency ratios could be used to measure how well West Pharmaceutical manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to gain to 0.17 in 2024. Return On Capital Employed is likely to gain to 0.22 in 2024. At this time, West Pharmaceutical's Total Current Liabilities is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 4 B in 2024, despite the fact that Change To Liabilities is likely to grow to (3.1 M).

Technical Drivers

As of the 26th of September, West Pharmaceutical maintains the Mean Deviation of 1.57, market risk adjusted performance of (0.14), and Standard Deviation of 2.55. Relative to fundamental indicators, the technical analysis model lets you check existing technical drivers of West Pharmaceutical Services, as well as the relationship between them.

West Pharmaceutical Price Movement Analysis

West Pharmaceutical Insider Trading Activities

West Pharmaceutical Outstanding Bonds

West Pharmaceutical Predictive Daily Indicators

West Pharmaceutical Corporate Filings

West Pharmaceutical Forecast Models

West Pharmaceutical's time-series forecasting models are one of many West Pharmaceutical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary West Pharmaceutical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how West Pharmaceutical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling West shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as West Pharmaceutical. By using and applying West Stock analysis, traders can create a robust methodology for identifying West entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. West analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. West analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

West Pharmaceutical Services stock analysis indicators help investors evaluate how West Pharmaceutical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading West Pharmaceutical shares will generate the highest return on investment. By understating and applying West Pharmaceutical stock analysis, traders can identify West Pharmaceutical position entry and exit signals to maximize returns.

When running West Pharmaceutical's price analysis, check to measure West Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy West Pharmaceutical is operating at the current time. Most of West Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of West Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move West Pharmaceutical's price. Additionally, you may evaluate how the addition of West Pharmaceutical to your portfolios can decrease your overall portfolio volatility.